ID: ALA147203

Max Phase: Preclinical

Molecular Formula: C10H21N3O8P2Pt+

Molecular Weight: 568.32

Molecule Type: Small molecule

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 568.32

Molecular Weight (Monoisotopic): 568.0446

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Galanski M, Slaby S, Jakupec MA, Keppler BK..  (2003)  Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.,  46  (23): [PMID:14584945] [10.1021/jm0308040]

2. Galanski M, Slaby S, Jakupec MA, Keppler BK..  (2003)  Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.,  46  (23): [PMID:14584945] [10.1021/jm0308040]

3. Galanski M, Slaby S, Jakupec MA, Keppler BK..  (2003)  Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.,  46  (23): [PMID:14584945] [10.1021/jm0308040]

Source

Source(1):

• Scientific Literature